Home › Us Fda warns India's Sun Pharma for violating manufacturing standards
 

Keywords :   


Us Fda warns India's Sun Pharma for violating manufacturing standards

2015-12-19 13:30:10| Chemicals - Topix.net

India's largest drugmaker Sun Pharmaceutical Industries Ltd said it had received a warning letter from the U.S. Food and Drug Administration for violating manufacturing standards at its Halol plant in western India. An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries in Mumbai.

Tags: sun standards manufacturing pharma

Category:Chemicals

Latest from this category

All news
05.07Covestro, Abu Dhabi National Oil Company Enter into Negotiations
05.07BCF Helps Transform More Than 800 Disused Phone Boxes
04.07 Mankiewicz Supplies Eye-catching Coatings for the CLAAS Anniversary Combine Harvester
03.07Axalta Completes Acquisition of The CoverFlexx Group
03.07RPM Declares Quarterly Dividend Payable on July 31, 2024
02.07Chattanooga Area High School Students Graduate from BASFs TECH Academy
02.07Fayette Pipe Transforms Black Steel Pipe with FayetteGuard
02.07Automotive Coatings to Reach $19B by 2028: MarketsandMarkets
Chemicals »
05.07Tropical Storm Beryl Graphics
05.07Atlantic Tropical Weather Outlook
05.07Tropical Storm Beryl Public Advisory Number 28A
05.07Summary for Tropical Storm Beryl (AT2/AL022024)
05.07Still no sign of herd rebuilding
05.07Eastern North Pacific Tropical Weather Outlook
05.07Tubi and Pluto lead U.S. surge in free streaming
05.07Tubi free streaming service launches in the UK
More »